English
Home > Products > Ganciclovir intermediate

China Ganciclovir intermediate Factory

Our enterprise aims to operating faithfully, serving to all of our prospects , and working in new technology and new machine frequently for Ganciclovir intermediate,CAS NO 3056-33-5,3056-33-5,Valacyclovir intermediate,Valacyclovir advance intermediate, We have ISO 9001 Certification and qualified this product or service .in excess of 16 years experiences in manufacturing and designing, so our goods featured with very best high-quality and aggressive rate. Welcome cooperation with us!
Ganciclovir intermediate, As an experienced manufacturer we also accept customized order and we could make it the same as your picture or sample specification. The main goal of our company is to live a satisfactory memory to all the customers, and establish a long term business relationship with buyers and users all over the world.

Related Products

Hot Products

  • Everolimus

    Everolimus

    Product Name:Everolimus
    Molecular Formula:C53H83NO14
    Molecular Weight;958.22
    CAS Registry Number;159351-69-6
  • Abacavir Sulfate

    Abacavir Sulfate

    Product Name:Abacavir Sulfate
    Molecular Formula:C28H38N12O6S
    Molecular Weight:670.74
    CAS Registry Number:188062-50-2
  • 1-(4-Aminophenyl)-4-(4-Hydroxyphenyl)Piperazine

    1-(4-Aminophenyl)-4-(4-Hydroxyphenyl)Piperazine

    Product Name:1-(4-Aminophenyl)-4-(4-hydroxyphenyl)piperazine
    Molecular Formula:C16H19N3O
    Molecular Weight:269.34
    CAS Registry Number:74853-08-0
  • Iodobenzene

    Iodobenzene

    Product Name:Iodobenzene
    Molecular Formula:C6H5I
    Molecular Weight:204.01
    CAS Registry Number:591-50-4
  • Diethoxymethane

    Diethoxymethane

    Product Name:Diethoxymethane
    Molecular Formula:C5H12O2
    Molecular Weight:104.15
    CAS Registry Number:462-95-3
  • Cyclophosphamide

    Cyclophosphamide

    Product Name:Cyclophosphamide
    Molecular Formula:C7H15Cl2N2O2P
    Molecular Weight:261.09
    CAS Registry Number:50-18-0
  • Related Blog
  • Reviews

  • TOP 8 Linezolid intermediate maker

    Sandoo Pharmaceuticals and Chemicals Co.,Ltd was established in 2009, with a creative and active team, located in Ningbo, China. We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10 years, covering more than 10 countries.

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • What Is Ursodeoxycholic Acid Used For?

    Ursodeoxycholic acid is a cholelithiant commonly used in the gastroenterology department, and also a cholelithiasis dissolving agent, so it can be used in the treatment of gallstones under normal circumstances, on the premise...

  • CAS 148553-50-8 What is Pregabalin?

    Pregabalin is an anti-epileptic drug, also called an anticonvulsant. It works by slowing down impulses within the brain that cause seizures. Pregabalin also affects chemicals within the brain that send pain signals across the systema nervosum.

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept